These findings have supported the view that genetic alterations that occur early during the genesis of colorectal cancer, such as APC, KRAS, NRAS and BRAF mutations, are maintained during the tumor evolution process until the final level of tumor metastases2,7. This evidence concerns the gene KRAS and colorectal cancer.